Inhibitory effects of Hibiscus sabdariffa L extract on low-density lipoprotein oxidation and anti-hyperlipidemia in fructose-fed and cholesterol-fed rats

Journal of the Science of Food and Agriculture

Volumn 84, Issue 15, 2004, Pages 1989-1996

  Chen, Chang Che ^a   Chou, Fen Pi ^a   Ho, Yung Chyan ^a   Lin, Wea Lung ^b   Wang, Chin Pin ^a   Kao, Erl Shyh ^a   Huang, An Chung ^a   Wang, Chau Jong ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti hyperlipidaemia; Antioxidation; Hibiscus sabdariffa L; High cholesterol diet; High fructose diet; Triglyceride

Indexed keywords

ANIMALIA; HIBISCUS; HIBISCUS SABDARIFFA;

EID: 8744317028     PISSN: 00225142     EISSN: None     Source Type: Journal    
DOI: 10.1002/jsfa.1872     Document Type: Article

References (37)

1. Steinberg D, Low-density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20 963-20 966 (1997).
2. Esterbauer H, Dieber-Rothaneder M, Waeg G, Striegl G and Jurgens G, Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 3:77-92 (1990).
3. Esterbauer H, Gebicki J, Puhl H and Jurgens G, The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13:341-390 (1992).
4. 2+ mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 17:1567-1572 (1994).
5. Lusis AJ, Atherosclerosis. Nature 407:233-241 (2000).
6. Glass CK and Witztum JL, Atherosclerosis: the road ahead. Cell 104:503-516 (2001).
7. 2+-mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 18:1-4 (1995).
8. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP and Rice-Evans C, Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322:339-346 (1995).
9. Jialal I, Norkus EP, Cristol L and Grundy SM, β-Carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1086:134-138 (1991).
10. Bjorkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L and Henriksson P, The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb 11:15-22 (1991).
11. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA and Willett WC, Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med 328:1450-1456 (1993).
12. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B and Willett WC, Vitamin E consumption and the risk of coronary disease in women. New Engl J Med 328:1444-1449 (1993).
13. Chobanian AV, Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolaemia coexist. Hypertension 18:130-131 (1991).
14. Cambien E, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P and Claude JR, Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. Am J Epidemiol 124:624-632 (1986).
15. Austin MA, Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 129:249-259 (1989).
16. Gordon T, Castelli WP, Hjortland MC, Kannel WB and Dawber TR, Predicting coronary heart disease in middle aged and older persons: the Framingham study. JAMA 238:497-499 (1977).
17. Gordon T, Castelli WP, Hjortland MC, Kannel WB and Dawber TR, High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 62:707-714 (1977).
18. Kannel WB, Castelli WP and Gordon T, Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 90:85-91 (1979).
19. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J and Wentworth D, Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 152:1490-1500 (1992).
20. Haji Faraji M and Haji Tarkhani A, The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmac 65:231-236 (1999).
21. Wang CJ, Wang JM, Lin WL, Chu CY, Chou FP and Taeng TH, Protective effect of Hibiscus anthocyanins against tert-butyl hydroperoxide-induced hepatic toxicity in rats. Food Chem Toxicol 38:411-416 (2000).
22. Vinson JA, Teufel K and Wu N, Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 156:67-72 (2001).
23. Tijburg LB, Wiseman SA, Meijer, GW and Weststrate JA, Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135:37-47 (1997).
24. Lee MJ, Chou FP, Tseng TH, Hsieh MH, Lin MC and Wang CJ, Protocatechuic acid or esculetin can inhibit oxidative LDL induced by either copper ion or nitric oxide donor. J Agric Food Chem 50:2130-2136 (2002).
25. Lakenbrink C, Lapczynski S, Maiwald B and Engelhardt UH, Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages. J Agric Food Chem 48:2848-2852 (2000).
26. Fuleki T and Francis FJ, Quantitative method for anthocyanins. II. Determination of total anthocyanins and degradative index for cranberry juice. J Food Sci 33:78-83 (1969).
27. Kawaii S, Tomono Y, Katase E, Ogawa K and Yano M, Quantitation of flavonoid constituents in citrus fruits. J Agric Food Chem 47:3565-3571 (1999).
28. Havel RJ, Eden HA and Bragdon JH, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J Clin Invest 34:1345-1353 (1995).
29. Cynshi O, Kawabe Y, Suzuki T, Takashima Y, Kaise H, Nakamura M, Ohba Y, Kato Y, Tamura K, Hayasaka A, Higashida A, Sakaguchi H, Takeya M, Takahashi K, Inoue K, Noguchi N, Niki E and Kodama T, Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc Natl Acad Sci USA 95:10 123-10 128 (1998).
30. Wallin B, Rosengren B, Shertzer HG and Camejo G, Lipoprotein oxidation and measurement of thiobarbituric acid reacting substrances formation in a single micortiter plate: its use for evaluation of antioxidants. Anal Biochem 208:10-15 (1993).
31. Wang IK, Lin-Shiau SY, Chen PC and Lin JK, Hypotriglyceridemic effect of anka (a fermented rice product of Monascus sp.) in rats. J Agric Food Chem 48:3183-3189 (2000).
32. Bravo L, Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56:317-333 (1998).
33. Manna C, Della Ragione F, Cucciolla V, Borriello A, D'Angelo S, Galletti P and Zappia V, Biological effects of hydroxytyrosol, a polyphenol from olive oil endowed with antioxidant activity. Adv Exp Med Biol 472:115-130 (1999).
34. Hertog MG, Feskens EJ, Hollman PC, Katan MB and Kromhout D, Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342:1007-1011 (1993).
35. Seeram NP and Nair MG, Inhibition of lipid peroxidation and structure activity related studies of the dietary constituents anthocyanins, anthocyanidins and catechins. J Agric Food Chem 50:5308-5012 (2002).
36. Tseng TH, Kao ES, Chu CY, Chou FP, Lin-Wu HW and Wang CJ, Protective effects of dried flower extracts of Hibiscus sabdariffa L. against oxidative stress in rat primary hepatocytes. Food Chem Toxicol 35:1159-1164 (1997).
37. Kannel WB, Castelli WP, Gordon T and McNamara PM, Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74:1-12 (1971).